Table 2. Univariable and final multivariable models for ESRD in the derivation cohort.
Variable | Univariable | Multivariable | ||
---|---|---|---|---|
OR (95% CI) | P | OR (95% CI) | P | |
Age (per 15-year increase) | 1.41 (0.98–2.03) | 0.069 | ||
Sex (male vs female) | 0.97 (0.63–1.48) | 0.883 | ||
Duration of DM (years) | 0.10 (0.97–1.03) | 0.987 | ||
Duration of hypertension (years) | 1.04 (1.01–1.08) | 0.024 | ||
Pathological grade | 1.89 (1.45–2.52) | <0.001 | 1.43 (1.04–1.98) | 0.03 |
RASB use | 0.24 (0.14–0.39) | <0.001 | ||
Hb (g/dL) | 0.97 (0.96–0.98) | <0.001 | ||
CRP (mg/l) PCT (ng/ml) |
0.10 (0.99–1.01) 0.94 (0.70–1.02) |
0.666 0.392 |
||
ESR (mm/l) | 1.01 (1.00–1.02) | <0.001 | ||
HbA1c (%) | 0.83 (0.75–0.93) | 0.001 | ||
Alb (g/L) | 0.96 (0.93–0.99) | 0.003 | ||
24hUTP (g) | 1.13 (1.07–1.20) | <0.001 | ||
Log urinary ACR (mg/g) | 1.61 (1.12–2.37) | 0.012 | 1.08 (1.01–1.16) | 0.04 |
TCr (g/g) | 1.11 (1.05–1.18) | <0.001 | ||
Scr (µmol/l) Urea (mmol/l) |
1.02 (1.01–1.03) 1.25 (1.18–1.34) |
<0.001 <0.001 |
||
Cystatin C (mg/l) | 5.77 (3.94–8.88) | <0.001 | 4.94 (3.34–7.66) | <0.001 |
TG (mmol/l) | 0.96 (0.86–1.06) | 0.430 | ||
HDL-cholesterol (mmol/l) | 0.78 (0.50–1.19) | 0.256 | ||
LDL-cholesterol (mmol/l) | 1.06 (0.93–1.21) | 0.390 | ||
Serum lipids | 0.24 (0.02–2.12) | 0.207 | ||
eGFR (ml/min/1.73 m2) | 0.95 (0.94–0.96) | <0.001 | 0.97(0.96–0.98) | <0.001 |
PTH (pg/ml) | 1.01 (1.00–1.02) | <0.001 | ||
BNP (pg/ml*103) | 1.08 (1.05–1.12) | <0.001 | 1.05 (1.01–1.10) | 0.01 |
CKmb (ng/ml) | 0.98 (0.97–0.99) | 0.04 |
Notes.
- DM
- Diabetes mellitus
- Hb
- Hemoglobin
- HbA1c
- Hemoglobin A1c
- Alb
- Albumin
- 24hUTP
- 24-hour total urine protein
- ACR
- Albumin-to-creatinine ratio
- Tcr
- Point total protein
- TG
- Triglycerides
- HDL-cholesterol
- High-density lipoprotein cholesterol
- LDL-cholesterol
- Low-density lipoprotein cholesterol
- Serum lipids
- HDL/total cholesterol ratio
- eGFR
- Estimated glomerular filtration rate
- PTH
- Parathyroid hormone
- RASB
- renin-angiotensin system blocker